Literature DB >> 1847215

Human rhinovirus 14 complexed with antiviral compound R 61837.

M S Chapman1, I Minor, M G Rossmann, G D Diana, K Andries.   

Abstract

The binding of the antirhinoviral agent R 61837 to human rhinovirus 14 has been examined by X-ray crystallographic methods. The compound R 61837 binds in the same pocket (underneath the canyon floor) as the "WIN" antirhinoviral agents. It does not penetrate as far into the pocket but causes similar conformational changes in the virus capsid. The movement of residues 1217 to 1221 of viral protein 1 (in the "FMDV loop") is more pronounced for R 61837 than for WIN compounds. Although both R 61837 and WIN antiviral agents partially fill the same hydrophobic pocket, atomic binding interactions differ, showing that considerable diversity in the nature of antiviral agents is possible.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847215     DOI: 10.1016/0022-2836(91)90749-v

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  18 in total

1.  An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.

Authors:  A W Dove; V R Racaniello
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Analysis of three structurally related antiviral compounds in complex with human rhinovirus 16.

Authors:  A T Hadfield; G D Diana; M G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Atomic structure of single-stranded DNA bacteriophage phi X174 and its functional implications.

Authors:  R McKenna; D Xia; P Willingmann; L L Ilag; S Krishnaswamy; M G Rossmann; N H Olson; T S Baker; N L Incardona
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

4.  Acid-induced structural changes in human rhinovirus 14: possible role in uncoating.

Authors:  V L Giranda; B A Heinz; M A Oliveira; I Minor; K H Kim; P R Kolatkar; M G Rossmann; R R Rueckert
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

5.  Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.

Authors:  M P Fox; M A McKinlay; G D Diana; F J Dutko
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

6.  SCH 48973: a potent, broad-spectrum, antienterovirus compound.

Authors:  P J Buontempo; S Cox; J Wright-Minogue; J L DeMartino; A M Skelton; E Ferrari; R Albin; E J Rozhon; V Girijavallabhan; J F Modlin; J F O'Connell
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

7.  Infectious cDNA clones of echovirus 12 and a variant resistant against the uncoating inhibitor rhodanine differ in seven amino acids.

Authors:  W Kraus; H Zimmermann; A Zimmermann; H J Eggers; B Nelsen-Salz
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

8.  Effect of a capsid-stabilizing pyridazinamine, R 78206, on the eclipse and intracellular location of poliovirus.

Authors:  O Ofori-Anyinam; R Vrijsen; P Kronenberger; A Boeyé
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.

Authors:  B Rombaut; B Verheyden; K Andries; A Boeyé
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Structural and virological studies of the stages of virus replication that are affected by antirhinovirus compounds.

Authors:  Ying Zhang; Alan A Simpson; Rebecca M Ledford; Carol M Bator; Sugoto Chakravarty; Gregory A Skochko; Tina M Demenczuk; Adiba Watanyar; Daniel C Pevear; Michael G Rossmann
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.